J. Wilańska

[Serum antiretinal antibodies (ARA) in patients with exudative age-related macular degeneration (AMD)--preliminary findings].

A. Kubicka-Trząska, J. Wilańska, 2009, Przeglad lekarski.

Autoimmune polyendocrine syndrome type 2 in patient with severe allergic asthma treated with omalizumab

J. Musial, S. Bazan-Socha, Weronika Zastrzeżyńska, 2018, The Journal of asthma : official journal of the Association for the Care of Asthma.

In reply to the comment of Dr Asaf Achiron to a paper: Circulating anti‐retinal antibodies in response to anti‐angiogenic therapy in exudative age‐related macular degeneration

M. Sanak, B. Romanowska-Dixon, A. Kubicka-Trząska, 2015, Acta ophthalmologica.

Serum anti‐endothelial cell antibodies in patients with age‐related macular degeneration treated with intravitreal bevacizumab

M. Sanak, B. Romanowska-Dixon, A. Kubicka-Trząska, 2016, Acta ophthalmologica.

Circulating anti‐retinal antibodies in response to anti‐angiogenic therapy in exudative age‐related macular degeneration

M. Sanak, B. Romanowska-Dixon, A. Kubicka-Trząska, 2014, Acta ophthalmologica.

Circulating antiretinal antibodies predict the outcome of anti‐VEGF therapy in patients with exudative age‐related macular degeneration

M. Sanak, B. Romanowska-Dixon, A. Kubicka-Trząska, 2012, Acta ophthalmologica.

Differences in anti-endothelial and anti-retinal antibody titers: implications for the pathohysiology of acute and chronic central serous chorioretinopathy.

M. Sanak, M. Jager, B. Romanowska-Dixon, 2020, Journal of Physiology and Pharmacology.

Circulating Anti-Endothelial Cell Antibodies in Patients with Geographic Atrophy Related to Dry Age-Related Macular Degeneration

B. Romanowska-Dixon, A. Kubicka-Trząska, I. Karska-Basta, 2024, Medicina.